2 min read

EverHint – Momentum Swing — Aggressive Momentum for Mar 10, 2026 – 2 Signals – Healthcare Leads (2)

2 signals. Healthcare leads (2). price range $33-$87. 1 report earnings within 7 days. full analyst coverage, earnings data, 50.0% have news.

What This Signal Is (Quick)

Aggressive Momentum is a momentum swing trading strategy focused on Triple threat: high momentum + high volume + high volatility.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

  • Stock showing strong momentum near or at highs
  • Increased volume confirms institutional interest
  • Breaking out or consolidating near resistance
  • Triple threat: high momentum + high volume + high volatility

Ideal For: Aggressive traders seeking maximum momentum with high risk/reward

Key Criteria:

  • Strong RSI momentum (configurable thresholds)

  • Volume surge above average

  • Price momentum confirmation

  • Minimum ADV: $25M+ (varies by variant)

  • Earnings buffer: 7 days pre/post earnings

  • Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High


How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)


📊 Momentum Swing — Aggressive Momentum Signals (2 Total)

Ranked by score:

Rank Ticker Company Sector Last ($) Score Vol Thrust @52w Days → Earnings Est EPS Mkt Cap ($B)
1 DNTH Dianthus Therapeutics,... Healthcare 86.92 1.000 2.43x 0.0% 0 $-3.57 3.1
2 CAPR Capricor Therapeutics,... Healthcare 33.40 0.000 3.59x 0.0% 8 $3.76 1.5

Field Notes

Sector concentration: Healthcare (2)

Near-term earnings: DNTH (Dianthus Therapeutics, Inc.) report within 7 days. Higher volatility risk.

Data coverage: 0.0% insider, 0.0% congressional, 100.0% earnings, 100.0% analyst, 50.0% news


Peer Analysis

Understanding how these stocks relate to their industry peers:

CAPR (Capricor Therapeutics, Inc.): Leads 10 peers: CABA ($3.32, +1.5%), LXEO ($7.20, -3.2%), PRQR ($1.80, -4.8%), TRDA ($13.20, +3.9%), IMMP ($2.76) | Peer of: ACHV ($4.28, +1.4%), CABA ($3.32, +1.5%), CADL ($5.11, -0.4%) and 11 more

DNTH (Dianthus Therapeutics, Inc.): Leads 8 peers: ELVN ($30.24, +1.7%), TSHA ($4.57, -0.4%), SANA ($3.29, -1.2%), ATAI ($4.14, +6.4%), NKTR ($72.07, +4.2%) | Peer of: ANAB ($62.01, +3.9%), ATAI ($4.14, +6.4%), ELVN ($30.24, +1.7%) and 8 more


Recent Headlines

CAPR (Capricor Therapeutics, Inc.)

  • What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? (source)

Market Context

Major indices are experiencing mild pullbacks, with the S&P 500 down 0.17%, Nasdaq off 0.11%, and Dow Jones slipping 0.14%, signaling a cautious short-term trend amid waning momentum. The VIX's rise to 24.93, up 2.21%, points to elevated volatility, which can amplify intraday swings ideal for aggressive momentum swing strategies. However, this heightened uncertainty demands tight risk management, as choppy conditions may lead to false breakouts or rapid reversals in momentum plays.

Risk appetite appears subdued in the broader market, with uniform declines across indices suggesting limited appetite for high-beta momentum trades. For aggressive swing strategies generating just two signals, this environment favors selective entries, particularly where volatility creates exploitable ranges without overextending into downtrends. Traders should prioritize quick exits to capitalize on swings while avoiding drawdowns in a risk-off tilt.

Healthcare as the top sector offers potential rotation appeal, potentially bucking the mild equity weakness if defensive qualities draw flows amid rising VIX. Momentum swings here could thrive on volatility-driven rotations, but overall trend caution implies scaling into positions cautiously to navigate sector-specific swings effectively.

Sharing Call-to-Action

🔍 If this breakdown was useful, feel free to like, share, or subscribe. Every bit of support matters.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/